CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for anemia in CLL patients: acalabrutinib trial shows promise
Disease control OngoingThis study tests a drug called acalabrutinib for people with chronic lymphocytic leukemia (CLL) who also have a type of anemia where the immune system attacks red blood cells. The goal is to see if the drug can control the anemia after other treatments have failed. Only 4 people …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New combo aims for Drug-Free remission in untreated CLL
Disease control OngoingThis study tests whether combining zanubrutinib (a pill that blocks cancer cell growth) with rituximab (an antibody infusion) can help people with previously untreated chronic lymphocytic leukemia (CLL) achieve a lasting remission without needing ongoing medication. About 60 adul…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:41 UTC